Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Results available

PRESERFLO® MicroShunt Extension Study

ClinicalTrials.gov ID: NCT04333433

Public ClinicalTrials.gov record NCT04333433. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 12:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Concurrent Controlled, Open-Label, Multicenter Clinical Study to Assess the Long-Term Safety of the PRESERFLO® MicroShunt in Subjects With Primary Open-Angle Glaucoma Who Have Completed Participation in the INN-005 Randomized Controlled Study.

Study identification

NCT ID
NCT04333433
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
InnFocus Inc.
Industry
Enrollment
279 participants

Conditions and interventions

Interventions

  • PRESERFLO® MicroShunt Device
  • Trabeculectomy Procedure

Device · Procedure

Eligibility (public fields only)

Age range
40 Years to 85 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 21, 2020
Primary completion
Nov 23, 2022
Completion
Nov 23, 2022
Last update posted
Mar 21, 2024

2020 – 2022

United States locations

U.S. sites
19
U.S. states
13
U.S. cities
19
Facility City State ZIP Site status
Arizona Advance Eye Research Institute, LLC. Glendale Arizona 85306
Vold Vision Fayetteville Arkansas 72704
UCLA Medical Center Jules Stein Eye Institute Los Angeles California 90095
University of California at Davis Eye Center Sacramento California 95817
Ophthalmic Consultants of Connecticut Meriden Connecticut 06450
Intermountain Eye Center Eagle Idaho 83616
Eugene and Marilyn Glick Eye Institute Indianapolis Indiana 46290
Stiles Eye Care Excellence & Glaucoma Institute Overland Park Kansas 66213
Minnesota Eye Consultants, PA Bloomington Minnesota 55431
New York Eye and Ear Infirmary of Mt. Sinai New York New York 10003
Glaucoma Consultants of the Capital Region Slingerlands New York 12159
Cincinnati Eye Institute Cincinnati Ohio 45242
Ophthalmic Surgeons and Consultants of Ohio Columbus Ohio 43215
Dean McGee Eye Institute Oklahoma City Oklahoma 73014
Ophthalmic Partners of Pennsylvania Bala-Cynwyd Pennsylvania 19004
Glaucoma Associates of Texas Dallas Texas 75231
Ophthalmology Associates Fort Worth Texas 76102
University Eye Associates Houston Texas 77030
R&R Eye Research, LLC San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04333433, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 21, 2024 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04333433 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →